FDA Approves Apomorphine Infusion Device SPN-830 as New Parkinson Treatment

  • Post category:New MG
In TOLEDO, the intervention group, with a mean final drug dose of 4.68 mg/hour, showed significant improvements, including a reduction in OFF time of …

Powered by WPeMatico